<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04446676</url>
  </required_header>
  <id_info>
    <org_study_id>Gruca Teaching Hospital</org_study_id>
    <nct_id>NCT04446676</nct_id>
  </id_info>
  <brief_title>Impact of the Type of Stabilization in the Two-stage Knee Reimplantation on Reinfection - Prospective, Randomized Study.</brief_title>
  <official_title>Impact of the Type of Stabilization in the Two-stage Knee Reimplantation on Reinfection - Prospective, Randomized Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof A Gruca Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Prof A Gruca Teaching Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants after first-stage of knee infection reimplantation will be assign to one of two
      groups: with stem vs. with sleeve. Investigators will check participants on clinical,
      laboratory and reinfection signs. The main hypothesis is that better mechanical stability of
      endoprosthesis with sleeves will support infection treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All participants will be treated because of periprosthetic joint infection of the knee, after
      primary arthroplasty. All participants will be treated with two-stage protocol. In first
      stage debridement and spacer implantation will be performed. After 6-week antibiotics, when
      will be absent clinical or laboratory signs of reinfection, second stage will be performed.
      All participants upon fulfillment all inclusion and exclusion criteria will sign informed
      consent. With computer software patients will be randomized to one of two groups: with stem
      vs. with sleeve. After operation all patients will get target antibiotics for 3 weeks.
      Pre-operation and after on periodic controls will checked the Knee Society Score, The Western
      Ontario and McMaster Universities Osteoarthritis Index(WOMAC), Visual Analogue Scale. After
      2-year observation evaluation of reinfection rate will be performed in both groups.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">January 2027</completion_date>
  <primary_completion_date type="Anticipated">July 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two groups with endoprosthesis stabilisation with stem or sleeve.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reinfection</measure>
    <time_frame>2 years</time_frame>
    <description>Rate of reinfection in both groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Loosening radiological signs</measure>
    <time_frame>2 years</time_frame>
    <description>Radiological evaluation of implant loosening with Modern Knee Society Radiographic Evaluation System</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Knee Society Score</measure>
    <time_frame>1 year</time_frame>
    <description>Clinical evaluation of patients after knee revision</description>
  </other_outcome>
  <other_outcome>
    <measure>The Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC)</measure>
    <time_frame>1 year</time_frame>
    <description>Clinical evaluation of patients after knee revision</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Analogue Score</measure>
    <time_frame>1 year</time_frame>
    <description>Clinical evaluation of patients after knee revision</description>
  </other_outcome>
  <other_outcome>
    <measure>Alignment</measure>
    <time_frame>6 weeks</time_frame>
    <description>Radiological alignment of knee after operation in degrees</description>
  </other_outcome>
  <other_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>1 year</time_frame>
    <description>After operation and at period controls (mg/l)</description>
  </other_outcome>
  <other_outcome>
    <measure>Erythrocyte sedimentation rate</measure>
    <time_frame>1 year</time_frame>
    <description>After operation and at period controls (mm/h)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Knee Infection</condition>
  <arm_group>
    <arm_group_label>Stem stabilization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of patients with stem endoprosthesis stabilization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sleeve stabilization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of patients with sleeve endoprosthesis stabilization</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stabilization with stem</intervention_name>
    <description>In both groups revision endoprosthesis of knee will be implanted with stem or sleeve stabilization.</description>
    <arm_group_label>Stem stabilization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stabilization with sleeve</intervention_name>
    <description>In both groups revision endoprosthesis of knee will be implanted with stem or sleeve stabilization.</description>
    <arm_group_label>Sleeve stabilization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  second-stage of knee reimplantation

          -  primary knee replacement in primary knee osteoarthritis

          -  fulfillment of International Consensus Meeting 2018 infection criteria

        Exclusion Criteria:

          -  intraoperative bone defects Anderson Orthopedic Research Institute score &gt;II

          -  autoimmune disease

          -  diabetes

          -  peripheral vascular disease

          -  congenital or acquired immunodeficiencies

          -  lack of pathogens after first-stage

          -  multi-bacterial infection

          -  multidirectional instability

          -  lack of patient consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paweł Bartosz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prof. A. Gruca Teaching Hospital in Otwock</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paweł Bartosz</last_name>
    <phone>+48 793629685</phone>
    <email>pbartosz@vp.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gruca Teaching Hospital, Centre of Postgraduate Medical Centre</name>
      <address>
        <city>Otwock</city>
        <state>Mazowieckie</state>
        <zip>05-400</zip>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <last_name>Paweł Bartosz</last_name>
      <phone>+48 793629685</phone>
      <email>pbartosz@vp.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 21, 2020</study_first_submitted>
  <study_first_submitted_qc>June 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2020</study_first_posted>
  <last_update_submitted>June 24, 2020</last_update_submitted>
  <last_update_submitted_qc>June 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Prof A Gruca Teaching Hospital</investigator_affiliation>
    <investigator_full_name>Bartosz Paweł</investigator_full_name>
    <investigator_title>M.D., Ph.D.</investigator_title>
  </responsible_party>
  <keyword>knee arthroplasty</keyword>
  <keyword>infection</keyword>
  <keyword>two-stage</keyword>
  <keyword>sleeve</keyword>
  <keyword>stem</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Study protocol and Informed consent form will be shared</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>1 year</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

